Por: New York Post Business March 22, 2023
Moderna’s chief executive on Wednesday defended the company’s plan to quadruple the price of its COVID-19 vaccine, telling US lawmakers it will no longer have the economies of scale from government procurement when the shots move into the private market. Moderna CEO Stephane Bancel was called to testify after the company flagged plans to drew the ire of Democratic Senator Bernie Sanders, who chairs the influential Committee on Health,... + full article
Portland Press Herald USA Health March 23, 2023
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Moderna CEO Stephane Bancel testifies during the Senate HELP... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Orlando Sentinel USA Nation March 23, 2023
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Stephane Bancel told the Senate Committee on Health,... + más
WPLG Local 10 USA Politics March 23, 2023
Associated Press USA Health March 22, 2023
MarketWatch USA Business February 28, 2023
The earnings announcement was a sort of rubber-hits-the-road moment for Moderna (ticker: MRNA), as investors, who have been generally anticipating a drop in Covid-19 vaccine sales ever since the jab first was authorized late 2020, for the first time could fully reckon what it... + más
Forbes USA Business November 29, 2022
Getty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
About iurex | Privacy Policy | Disclaimer |